Work

A phase II trial on the combination of bevacizumab and irinotecan in recurrent ovarian cancer.

Year: 2014

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2014.32.15_suppl.5564

Authors: Huichung Tina Ling, Franco Muggia, James L. Speyer, John Patrick Curtin, Stephanie V. Blank, Leslie R. Boyd, Bhavana Pothuri, Xiaochun Li, Judith D. Goldberg, Amy Tiersten

Institutions: Kaiser Permanente Hayward Medical Center, New York University

Language: English

Topic: Ovarian cancer diagnosis and treatment

Subfield: Reproductive Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2600554834

Cites:

Cited by: 2

Related to: 10